Mortality in Hospitalised HIV/AIDS Patients in a Tertiary Centre in Sub-Saharan Africa: Trends Between 2007 and 2015, Causes and Associated Factors

Author:

Luma Henry Namme,Mboringong Fanny,Doualla Marie-Solange,Nji Miriam,Donfack Olivier-Tresor,Kamdem Felicite,Ngouadjeu Eveline,Lepka Fernando Kemta,Mapoure Yakouba Njankou,Mbatchou Hugo Bertrand

Abstract

Background: With easy accessibility to combination Antiretroviral Therapy (cART), mortality amongst hospitalized HIV/AIDS patients needs to be described. Objective: We aimed at determining the trends, causes and factors associated with in-hospital mortality amongst HIV/AIDS patients in the Douala General Hospital. Methods: We retrospectively reviewed hospitalisation records of HIV/AIDS patients hospitalized in the medical wards of the DGH from 2007 to 2015. Four cause-of-death categories were defined: 1. Communicable conditions and AIDS-defining malignancies, 2. Chronic non-communicable conditions and non-AIDS defining malignancies’, 3. Other non-communicable conditions and 4. Unknown conditions. Logistic regression was used to determine factors associated mortality. Results: We analyzed 891 eligible files. The mean age was 43 (standard deviation (SD): 10) years and median length of hospital stay was 9 (interquatile range (IQR)4 - 15) days. The overall all-cause mortality was 23.5% (95% CI: 20.8% - 26.4%). The category - communicable conditions and AIDS defining malignancies represented 79.9%, of deaths and this remained constant for each year during the study period. Tuberculosis was the most common specific cause of death (23.9%). Patients who had two (OR=2.35, 95%CI: 1.35 - 4.06) and more than two (OR=4.23, 95%CI: 1.62 – 11.12) opportunistic infections, a haemoglobin level less than 10g/l (OR=2.38, 95%CI: 1.58 - 3.59) had increased odds of dying. Conclusion: In-hospital mortality is high amongst HIV/AIDS patients at the Douala general hospital. The category - communicable conditions and AIDS defining malignancies - is still the main underlying cause of death. We hope that our findings will help to develop interventions aimed at reducing in-hospital mortality.

Publisher

Bentham Science Publishers Ltd.

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health

Reference48 articles.

1. UNAIDS 2017. Available from: http:/ /www.aidsdatahub.org/ sites/default/ files/ publication/ UNAIDS_Global_ AIDS_Update_ 2017_Data _book_2017 _en.pdf.

2. WHO. Summary of the global HIV epidemic 2016. Available from: http://www.who.int/hiv/data/epi_core_2016.png

3. WHO. World Health Organization WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children 2007 2007.

4. Stebbing J, Bower M, Mandalia S, Nelson M, Gazzard B. Highly Active Anti-Retroviral Therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality. Clin Exp Immunol 2006; 145 (2) : 271-6.

5. Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use of Highly Active Anti-Retroviral Therapy (HAART) in patients with advanced HIV infection: Impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage 2001; 21 (1) : 41-51.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3